0
0
Read Time:12 Second
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 15, 2025, titled “Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %